Information  X 
Enter a valid email address

Scancell Holdings PLC Ord 0.1P (SCLP)

Date Time Source Announcement
20 May 2019 7:00 am
RNS
Scancell and CRUK provide an update on SCIB2
10 May 2019 7:00 am
RNS
Clinical Advisory Board and Update on Modi-1
25 Apr 2019 7:00 am
RNS
UK approval to start SCIB1 Phase 2 trial
08 Apr 2019 7:00 am
RNS
Japan patent for Moditope immunotherapy platform
21 Mar 2019 7:00 am
RNS
Professor Lindy Durrant receives Waldenstr?m award
20 Mar 2019 7:00 am
RNS
Scancell strengthens IP portfolio
05 Mar 2019 6:27 pm
RNS
Holding(s) in Company
04 Mar 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
21 Feb 2019 7:00 am
RNS
Change of Auditor
31 Jan 2019 7:00 am
RNS
Interim Results
23 Jan 2019 7:00 am
RNS
Update on Cancer Research UK's Grand Challenge
21 Jan 2019 7:00 am
RNS
Appoints Heads of Research and Manufacturing
12 Nov 2018 7:00 am
RNS
Scancell to Present at Two Conferences
01 Nov 2018 7:00 am
RNS
Scancell to present at Proactive Investors Forum
30 Oct 2018 5:18 pm
RNS
Results of AGM
  7:00 am
RNS
Identification of 2nd Moditope Cancer Vaccine
24 Oct 2018 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Update on SCIB1 Phase 2 Clinical Study
05 Oct 2018 7:00 am
RNS
Notice of AGM
25 Sep 2018 7:00 am
RNS
Final Results for the year ended 30 April 2018
18 Sep 2018 7:00 am
RNS
Notice of Final Results
10 Aug 2018 7:00 am
RNS
Board Change
09 Aug 2018 7:00 am
RNS
Agreement
25 Jul 2018 2:45 pm
RNS
Director/PDMR Shareholding
24 Jul 2018 7:00 am
RNS
Issue of Equity
18 Jul 2018 7:00 am
RNS
Scancell exercises TriGrid commercial option
23 May 2018 7:00 am
RNS
Grant of European patent for Moditope platform
11 May 2018 1:11 pm
RNS
Holding(s) in Company
  1:11 pm
RNS
Holding(s) in Company
09 May 2018 10:12 am
RNS
Holding(s) in Company
08 May 2018 7:00 am
RNS
Result of the Open Offer and PDMR Shareholdings
23 Apr 2018 12:43 pm
RNS
Holding(s) in Company
  12:43 pm
RNS
Holding(s) in Company
20 Apr 2018 4:32 pm
RNS
Holding(s) in Company
18 Apr 2018 2:29 pm
RNS
Result of Placing and Subscription and PDMR
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Proposed Placing, Subscription and Open Offer
  7:00 am
RNS
Technology acquired from University of Nottingham
03 Apr 2018 7:00 am
RNS
Manufacturing agreement with The PolyPeptide Group
16 Feb 2018 11:30 am
RNS
Scancell to present at the Calculus Investor Forum
15 Feb 2018 7:15 am
RNS
Hardman Res. - Validating multiple opportunities
  7:00 am
RNS
Collaboration agreement with ISA Pharmaceuticals
12 Feb 2018 7:00 am
RNS
Publication highlights potential of SCIB1 therapy
09 Feb 2018 7:00 am
RNS
European patent application allowed for grant
08 Feb 2018 7:00 am
RNS
Scancell member of team shortlisted for CRUK award
01 Feb 2018 7:00 am
RNS
Director/PDMR Shareholding
30 Jan 2018 7:00 am
RNS
Half-year Report
09 Jan 2018 7:00 am
RNS
Scancell to collaborate with BioNTech
14 Dec 2017 7:00 am
RNS
Scancell and CRUK to advance cancer immunotherapy
11 Oct 2017 9:44 am
RNS
Result of AGM
10 Oct 2017 7:00 am
RNS
Directorate Change
14 Sep 2017 7:00 am
RNS
Notice of AGM
13 Sep 2017 7:00 am
RNS
Final Results
11 Sep 2017 7:00 am
RNS
Presents Moditope Data at Immunotherapy Conference
29 Aug 2017 7:00 am
RNS
Oncimmune and Scancell Present Autoantibodies Data
11 Jul 2017 7:00 am
RNS
Continued Progress on SCIB1
26 Jun 2017 7:00 am
RNS
DNA ImmunoBody Patent Granted in Europe
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t